These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9466283)

  • 1. Bronchoalveolar lavage cell composition in allogeneic bone marrow transplant patients without symptomatic lung complications.
    de la Cámara R; Girón R; Marrón C; Martínez C; Ancochea J; Fernández-Rañada JM; Aspa J
    Bone Marrow Transplant; 1997 Dec; 20(12):1087-93. PubMed ID: 9466283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar cytology for diagnosing pulmonary GVHD after bone marrow transplant in children.
    Rochat I; Posfay-Barbe KM; Kumar N; Pache JC; Kaiser L; Ozsahin H; Barazzone Argiroffo C; Bongiovanni M
    Pediatr Pulmonol; 2008 Jul; 43(7):697-702. PubMed ID: 18500739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2, interferon-gamma and natural killer cell activity in bronchoalveolar lavage fluid from marrow transplant recipients with cytomegalovirus pneumonia.
    Slavin M; Dobbs S; Crawford S; Bowden R
    Bone Marrow Transplant; 1993 Feb; 11(2):113-8. PubMed ID: 8382095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alveolar lavage cytological data in lung transplants free of bronchial superinfection. Toulouse Lung Transplantation Group].
    Courtade M; Carré P; Martel S; Caratero A; Caratero C; Thach KS; Léophonte P
    Rev Mal Respir; 1996; 13(4):413-20. PubMed ID: 8927795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bronchoalveolar lavage cytology and determination of protein contents in pulmonary complications of bone marrow transplant recipients.
    Leskinen R; Taskinen E; Volin L; Tukiainen P; Ruutu T; Häyry P
    Bone Marrow Transplant; 1990 Apr; 5(4):241-5. PubMed ID: 2159819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantation.
    Yurovsky VV; Cottler-Fox MH; Atamas SP; Shanholtz CB; Britt EJ; Sensenbrenner LL; White B
    Am J Hematol; 2001 Jan; 66(1):1-11. PubMed ID: 11426485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of bronchoalveolar lavage fluid in patients before and after bone marrow transplantation].
    Yasui M; Nishi K; Fujimura M; Nomura M; Kurashima K; Shintani H; Sayuri S; Yasuhito N; Matsuda T; Saito M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):51-6. PubMed ID: 1625396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
    Majhail NS; Parks K; Defor TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1038-46. PubMed ID: 17067910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of increased bronchoalveolar lavage fluid albumin and serum beta 2-microglobulin with pulmonary complications after allogeneic bone marrow transplantation.
    Kreuzfelder E; Quabeck K; Braun M; Weber W; Westhoff U; Schaefer UW; Bruch J; Costabel U; Grosse-Wilde H
    Bone Marrow Transplant; 1995 Aug; 16(2):249-52. PubMed ID: 7581143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation.
    Buchbinder S; Elmaagacli AH; Schaefer UW; Roggendorf M
    Bone Marrow Transplant; 2000 Sep; 26(6):639-44. PubMed ID: 11035370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
    Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
    Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of human cytomegalovirus using bronchoalveolar lavage cells in pulmonary complications associated with hematologic neoplasia.
    Ohyashiki JH; Nagate A; Ojima T; Abe K; Yamamoto K; Ohyashiki K
    Int J Mol Med; 2003 Jun; 11(6):779-83. PubMed ID: 12736722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lung site and fluid volume on results of bronchoalveolar lavage fluid analysis in horses.
    Sweeney CR; Rossier Y; Ziemer EL; Lindborg S
    Am J Vet Res; 1992 Aug; 53(8):1376-9. PubMed ID: 1510313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential cytology of bronchoalveolar lavage fluid in healthy children in comparison with children colonized by lung-specific pathogens].
    Ahrens P; Zielen S; Kitz R; Hofmann D
    Pneumologie; 1997 Feb; 51(2):99-103. PubMed ID: 9157458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of cytomegalovirus antigen on alveolar cells in bronchoalveolar fluid from transplant patients with cytomegalovirus pneumonia.
    Heurlin N; Markling L; Barkholt L; Lönnqvist B; Andersson J; Ringdén O
    Clin Transplant; 1994 Oct; 8(5):466-73. PubMed ID: 7819613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical cells in bronchoalveolar lavage specimens from bone marrow transplant recipients. A potential pitfall.
    Gulbahce HE; Baker KS; Kumar P; Kjeldahl K; Pambuccian SE
    Am J Clin Pathol; 2003 Jul; 120(1):101-6. PubMed ID: 12866379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
    Trenschel R; Ross S; Hüsing J; Ottinger H; Elmaagacli A; Roggendorf M; Schaefer UW; Runde V
    Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in bronchoalveolar lavage in 77 patients with bone marrow transplants.
    Abu-Farsakh HA; Katz RL; Atkinson N; Champlin RE
    Acta Cytol; 1995; 39(6):1081-8. PubMed ID: 7483980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.